Combined chemotherapy and radiotherapy in patients with advanced squamous carcinoma of the cervix (cis-platinum-bleomycin-vinblastine)

R. Soeters, B. Bloch, W. Levin, C. M D Dehaeck, G. Goldberg

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In a pilot study, nine patients with advanced carcinoma of the cervix were treated with combination chemotherapy including cis-platinum, vinblastine, and bleomycin repeated at 3-week intervals for three courses followed by radiotherapy. Only one patient showed a partial response (reduction of tumor size more than 50%). There were no complete responses. Five of the nine patients have died from the disease with a median survival time of 20 months. These findings suggest that this particular combination of chemotherapy with radiotherapy does not have a significant effect in patients with advanced stage carcinoma of the cervix.

Original languageEnglish (US)
Pages (from-to)44-45
Number of pages2
JournalGynecologic Oncology
Volume33
Issue number1
DOIs
StatePublished - 1989
Externally publishedYes

Fingerprint

Vinblastine
Bleomycin
Cervix Uteri
Cisplatin
Squamous Cell Carcinoma
Radiotherapy
Drug Therapy
Combination Drug Therapy
Carcinoma
Survival
Neoplasms

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Combined chemotherapy and radiotherapy in patients with advanced squamous carcinoma of the cervix (cis-platinum-bleomycin-vinblastine). / Soeters, R.; Bloch, B.; Levin, W.; Dehaeck, C. M D; Goldberg, G.

In: Gynecologic Oncology, Vol. 33, No. 1, 1989, p. 44-45.

Research output: Contribution to journalArticle

Soeters, R. ; Bloch, B. ; Levin, W. ; Dehaeck, C. M D ; Goldberg, G. / Combined chemotherapy and radiotherapy in patients with advanced squamous carcinoma of the cervix (cis-platinum-bleomycin-vinblastine). In: Gynecologic Oncology. 1989 ; Vol. 33, No. 1. pp. 44-45.
@article{60cf3be075044df4bb786f9e092b32e0,
title = "Combined chemotherapy and radiotherapy in patients with advanced squamous carcinoma of the cervix (cis-platinum-bleomycin-vinblastine)",
abstract = "In a pilot study, nine patients with advanced carcinoma of the cervix were treated with combination chemotherapy including cis-platinum, vinblastine, and bleomycin repeated at 3-week intervals for three courses followed by radiotherapy. Only one patient showed a partial response (reduction of tumor size more than 50{\%}). There were no complete responses. Five of the nine patients have died from the disease with a median survival time of 20 months. These findings suggest that this particular combination of chemotherapy with radiotherapy does not have a significant effect in patients with advanced stage carcinoma of the cervix.",
author = "R. Soeters and B. Bloch and W. Levin and Dehaeck, {C. M D} and G. Goldberg",
year = "1989",
doi = "10.1016/0090-8258(89)90600-8",
language = "English (US)",
volume = "33",
pages = "44--45",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Combined chemotherapy and radiotherapy in patients with advanced squamous carcinoma of the cervix (cis-platinum-bleomycin-vinblastine)

AU - Soeters, R.

AU - Bloch, B.

AU - Levin, W.

AU - Dehaeck, C. M D

AU - Goldberg, G.

PY - 1989

Y1 - 1989

N2 - In a pilot study, nine patients with advanced carcinoma of the cervix were treated with combination chemotherapy including cis-platinum, vinblastine, and bleomycin repeated at 3-week intervals for three courses followed by radiotherapy. Only one patient showed a partial response (reduction of tumor size more than 50%). There were no complete responses. Five of the nine patients have died from the disease with a median survival time of 20 months. These findings suggest that this particular combination of chemotherapy with radiotherapy does not have a significant effect in patients with advanced stage carcinoma of the cervix.

AB - In a pilot study, nine patients with advanced carcinoma of the cervix were treated with combination chemotherapy including cis-platinum, vinblastine, and bleomycin repeated at 3-week intervals for three courses followed by radiotherapy. Only one patient showed a partial response (reduction of tumor size more than 50%). There were no complete responses. Five of the nine patients have died from the disease with a median survival time of 20 months. These findings suggest that this particular combination of chemotherapy with radiotherapy does not have a significant effect in patients with advanced stage carcinoma of the cervix.

UR - http://www.scopus.com/inward/record.url?scp=0024520985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024520985&partnerID=8YFLogxK

U2 - 10.1016/0090-8258(89)90600-8

DO - 10.1016/0090-8258(89)90600-8

M3 - Article

VL - 33

SP - 44

EP - 45

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -